What is the most recent earnings date for SELB stock?
SELECTA BIOSCIENCES INC (SELB) last reported earnings on 11/9/2023.
NASDAQ:SELB • US8162121045
Past quarterly earnings results for SELECTA BIOSCIENCES INC (SELB), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q2 2023 | -0.07 | -0.08 | 14.22% | -216.67% | 5.249M | 11.314M | -53.61% | -86.63% |
| Q1 2023 | -0.14 | -0.09 | -57.51% | -160.87% | 5.938M | 12.07M | -50.80% | -82.53% |
| Q4 2022 | 0.04 | -0.07 | 153.82% | 33.33% | 16.795M | 11.918M | 40.92% | -43.90% |
| Q3 2022 | -0.05 | -0.01 | -758.49% | 68.75% | 20.71M | 25.719M | -19.48% | -15.22% |
| Q2 2022 | 0.06 | -0.08 | 176.26% | 50.00% | 39.273M | 14.057M | 179.38% | 99.73% |
| Q1 2022 | 0.23 | -0.11 | 308.15% | 204.55% | 33.999M | 13.378M | 154.14% | 207.68% |
| Q4 2021 | 0.03 | -0.07 | 140.37% | 121.43% | 29.937M | 17.936M | 66.91% | 150.52% |
| Q3 2021 | -0.16 | -0.08 | -111.15% | -77.78% | 24.427M | 12.431M | 96.50% | 425.31% |
| Q2 2021 | 0.04 | -0.12 | 133.48% | 116.00% | 19.663M | 7.273M | 170.36% | - |
| Q1 2021 | -0.22 | -0.12 | -76.79% | -4.76% | 11.05M | 7.672M | 44.03% | - |
| Q4 2020 | -0.14 | -0.12 | -18.62% | - | 11.95M | 5.571M | 114.50% | - |
| Q3 2020 | -0.09 | 0.06 | -247.06% | - | 4.65M | 21.356M | -78.23% | - |
| Q2 2020 | -0.25 | -0.01 | -3,167.97% | - | 19.125M | -100.00% | - | |
| Q1 2020 | -0.21 | -0.29 | 26.40% | - | - | - |
Notes
SELECTA BIOSCIENCES INC (SELB) last reported earnings on 11/9/2023.
SELECTA BIOSCIENCES INC (SELB) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, SELECTA BIOSCIENCES INC (SELB) has beaten EPS estimates in 2 out of 4 releases.